Kwality Pharmaceuticals Limited (NSE:KPL)

Kwality Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Kwality Pharmaceuticals had annual revenue of 5.03B INR with 35.90% growth. Kwality Pharmaceuticals had revenue of 1.57B in the quarter ending March 31, 2026, with 35.82% growth.

• Revenue: 5.03B
• Revenue Growth: +35.90%
• P/S Ratio: 4.40
• Revenue / Employee: 5.05M
• Employees: 997
• Market Cap: 22.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.03B	1.33B	35.90%
Mar 31, 2025	3.70B	630.25M	20.52%
Mar 31, 2024	3.07B	561.42M	22.36%
Mar 31, 2023	2.51B	-2.05B	-44.97%
Mar 31, 2022	4.56B	1.93B	73.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error